Drug intelligence / Profile preview

miR-367-3p mimic

Development stage
Preclinical
Modality
MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense DNA → DNA Therapeutics → Nucleic Acid Therapeutics, Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
Administration
Intravenous, Intratumoral
01

Overview

miR-367-3p mimic is a synthetic, double-stranded RNA oligonucleotide designed to simulate the biological activity of the endogenous microRNA miR-367-3p. It functions as a tumor suppressor by participating in the RNA-induced silencing complex (RISC) to post-transcriptionally regulate gene expression. Specifically, it binds to the 3' untranslated region (UTR) of target messenger RNAs (mRNAs), such as RAB23, leading to their degradation or translational inhibition. In preclinical models of bladder cancer, the administration of miR-367-3p mimics has been shown to inhibit cell proliferation, migration, and invasion, while also enhancing the sensitivity of cancer cells to chemotherapeutic agents like cisplatin. This molecule represents an experimental approach in RNA-based therapeutics for oncology, aimed at restoring the levels of tumor-suppressive miRNAs that are frequently downregulated in various cancers.

Other names
microRNA-367-3p mimicmicroRNA367-3p mimicmicroRNA 367-3p mimichsa-miR-367-3p mimichsa-miR367-3p mimichsa-miR 367-3p mimic
02

Targets

HMGA2 (High mobility group AT-hook 2)

Beyond the preview

Go deeper on miR-367-3p mimic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on miR-367-3p mimic.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call